Venture Life projects strong H2 after securing European access

Venture Life Group on Thursday reported half-year results in line with expectations as it forecasted a “stronger” second half after its European expansion comes into effect.

The healthcare firm reported a 6% rise in revenues to £8.3m in a trading update for the six months ended 30 June, and expected this growth to increase when the company’s French partner launches products from the UltraDEX range in Spain, Portugal and Belgium in the fourth quarter.

The partnership with La Brosse et Dupont will also see the launch of UltraDEX One Go liquid sachets and UltraDEX sensitive toothpaste into the French mass market at roughly the same date.

"We are delighted to extend our relationship with our key French partner into additional markets in the EU and particularly into the mass market. La Brosse et DuPont has made an excellent start to its launch of UltraDEX mouthwash in France, and has already extended the range to include both the sensitive toothpaste and One Go products," said chief executive Jerry Randall.

Further partnership deals for access to the Austrian and United Arab Emirates markets will also be launched in the first quarter of next year at the latest.

The AIM traded company will also see its first contribution from the newly acquired oral care brand Dentyl, which came under the Venture Life umbrella on 7 August.

"The acquisition of this valuable brand is another step in our strategic path to grow revenues and utilise the significant operating leverage we possess to drive profit growth. We continue to use this route in the future to bring more interesting assets into the company," said Randall.

Venture Life shares were up 1.73% at 47.00p at 0846 BST.